Within nanoGUNE’s strategic portfolio of technologies there are eight high-impact technologies in the biomedical sector. nanoGUNE’s entry into the Basque Health Cluster is a strategic, high added-value move. The Basque Health Cluster will operate as a transfer bridge between the front-line research being done at nanoGUNE and the current needs of companies in the biomedical sector.
The Basque Health Cluster is a not-for-profit association that aims to coordinate, represent, manage, promote and defend the shared interests of the partner companies, in collaboration with the public administrations and with other organisations in the field of biosciences and health. It also seeks to contribute towards the development, growth and internationalisation of its partners and the biosciences and health sector in the Basque Autonomous Community. Its main areas of activity (59%) are biotechnology applied to health, both human and animal, the agri-food sector, cosmetics, medical devices, e-health, management, transversal services, etc. Diagnostics stands out within these areas of action.
Set up by Catalan companies in 2012, the Packaging Cluster currently brings together 73 active members from among companies, knowledge centres and organisations working in the field of packaging and packing. The main aim of the Packaging Cluster is to further the competitive improvement of the companies that form it in order to generate more and better business for companies and organisations in the field of packaging and packing.
AFM cluster acts as a bridge between nanoGUNE and the industry in which clients can find highly innovative solutions to their day to day technical needs. Along with the AFM Cluster, nanoGUNE works on the optimisation of processes or material´s properties that indirectly can lead to a cost reduction in the industry.
Nanomedicine platform offers nanoGUNE the international prospective and visibility of the biotech based technologies in its portfolio. The platform allows a highly productive networking with the key players in the sector and the direct contact with a panel of experts evaluating the potential market of our niche technologies.